Natural killer (NK) cells are attractive within adoptive transfer settings in cancer
immunotherapy due to their potential for allogeneic use; their alloreactivity is enhanced …

Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer mortality and
a common poor-prognosis malignancy due to postoperative recurrence and metastasis …

Ovarian cancer (OC) is a lethal gynecologic malignancy, with modest responses to CPI.
Engagement of additional immune arms, such as NK cells, may be of value. We focused on …

Natural killer (NK) cells recognize deranged cells that display stress receptors or loss of
major histocompatibility complex (MHC) class I. During development, NK cells become …

Cell surface biochemical changes, notably excessive increase in outer leaflet sphingomyelin
(SM) content, are important in cancer initiation, growth, and immune evasion. Innumerable …

Natural killer (NK) cells are increasingly used in clinical studies in order to treat patients with
various malignancies. The following review summarizes platform lectures and 2013–2015 …

One area of cancer research is the interaction between cancer cells and immune cells, in
which chemokines play a vital role. Despite this, a comprehensive summary of the …

Signal transducer and activator of transcription 3 (STAT3) is a member of the Janus kinase
(JAK)-STAT pathway, which is one of the key pathways contributing to cancer. STAT3 …

Natural killer (NK) cells play an important role in tumor immunotherapy with their unique
capability of killing transformed cells without the need for prior sensitization and without …

Tumor micro‐environment has potential to customize the behavior of the immune cell
according to their need. In immune‐eliminating phase, immune cells eliminate transformed …